At what age can Flonase (fluticasone propionate) nasal spray be administered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Flonase Can Be Given Starting at Age 4 Years

Fluticasone propionate nasal spray (Flonase) is FDA-approved for use in children aged 4 years and older 1, 2. This represents the minimum age at which this medication can be safely administered.

Age-Specific Dosing

Children 4-11 Years

  • Dose: 1 spray per nostril once daily 1, 2
  • Important limitation: Children should use this medication for the shortest duration necessary to achieve symptom relief 2
  • Duration concern: If your child needs to use the spray for longer than 2 months per year, consult their physician, as growth rate may be slower with prolonged use 2, 3
  • Supervision required: An adult should supervise administration 2

Children 12 Years and Older (and Adults)

  • Week 1: 2 sprays per nostril once daily 2
  • Weeks 2-6 months: 1-2 sprays per nostril once daily as needed 2
  • After 6 months: Consult physician before continuing 2

Children Under 4 Years

  • Do not use 2

Clinical Context and Alternatives

The 2015 American Academy of Otolaryngology-Head and Neck Surgery guidelines confirm fluticasone propionate is approved for ages ≥4 years for both allergic rhinitis and nonallergic rhinitis 1. This guideline represents high-quality evidence (Grade A) based on randomized controlled trials.

For younger children (ages 2-3 years), alternative intranasal corticosteroids are available:

  • Mometasone furoate (Nasonex): Approved for ≥2 years 1
  • Fluticasone furoate (Veramyst): Approved for ≥2 years 1
  • Triamcinolone acetonide (Nasacort): Approved for ≥2 years and available over-the-counter 1

Important Safety Considerations

Growth monitoring is essential in prepubescent children using intranasal corticosteroids. A 2014 study demonstrated that fluticasone furoate reduced growth velocity by approximately 0.27 cm/year compared to placebo in children ages 5-8.5 years 3. While this effect is small, it underscores the importance of:

  • Using the lowest effective dose
  • Limiting duration to what is clinically necessary
  • Regular monitoring by a physician if prolonged use is required

Common side effects in children include headache, pharyngitis, epistaxis, nasal burning or irritation, nausea/vomiting, asthma symptoms, and cough 1.

Practical Prescribing Points

The FDA label explicitly states that children 4-11 years should not use Flonase for more than 2 months per year without physician consultation 2. This is a critical counseling point for parents and caregivers.

Research supports the efficacy and safety of fluticasone propionate in children as young as 4 years, with studies demonstrating significant symptom improvement without interference with the hypothalamic-pituitary-adrenal axis at recommended doses 4, 5.

References

Guideline

clinical practice guideline: allergic rhinitis.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2015

Research

Fluticasone propionate aqueous nasal spray treatment for perennial allergic rhinitis in children.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.